British journal of Cancer |
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial |
avr. 19 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
The impact of age on complications, survival, and cause of death following colon cancer surgery |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma |
sep. 15 |
1 ♥ |
Carcinome hépatocellulaire (CHC), Foie |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours |
sep. 17 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma |
juil. 18 |
|
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial |
oct. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial |
mai. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients |
oct. 17 |
3 ♥ |
Cancers autres |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Journal of the National Cancer Institute (JNCI) |
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome |
juin. 15 |
3 ♥ |
Cancer colorectal (CCR), Génétique |
Journal of the National Cancer Institute (JNCI) |
Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer |
mai. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers |
juil. 16 |
3 ♥ |
Cancers autres (hors CCR et CHC), Œsophage/Estomac, Endoscopie/Imagerie |